000			01547 a2200409 4500
005			20250513222317.0
264		0	_c20010111
008			200101s 0 0 eng d
022			_a0898-6568
024	7		_a10.1016/s0898-6568(00)00105-4 _2doi
040			_aNLM _beng _cNLM
100	1		_aSipeki, S
245	0	0	_aProtein kinase C decreases the hepatocyte growth factor-induced activation of Erk1/Erk2 MAP kinases. _h[electronic resource]
260			_bCellular signalling _cAug 2000
300			_a549-55 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aEnzyme Activation
650	0	4	_aGene Expression Regulation
650	0	4	_aHepatocyte Growth Factor _xpharmacology
650	0	4	_aHumans
650	0	4	_aMAP Kinase Signaling System
650	0	4	_aMitogen-Activated Protein Kinase 1 _xmetabolism
650	0	4	_aMitogen-Activated Protein Kinase 3
650	0	4	_aMitogen-Activated Protein Kinases _xmetabolism
650	0	4	_aPhosphatidylinositol 3-Kinases _xmetabolism
650	0	4	_aPhosphorylation
650	0	4	_aProtein Kinase C _xdrug effects
650	0	4	_aTetradecanoylphorbol Acetate _xpharmacology
650	0	4	_aTumor Cells, Cultured
700	1		_aBander, E
700	1		_aFarkas, G
700	1		_aGujdár, A
700	1		_aWays, D K
700	1		_aFaragó, A
773	0		_tCellular signalling _gvol. 12 _gno. 8 _gp. 549-55
856	4	0	_uhttps://doi.org/10.1016/s0898-6568(00)00105-4 _zAvailable from publisher's website
999			_c10973075 _d10973075